Michael H Antoni Selected Research

Biological Factors

4/2024	Avanzando Caminos (Leading Pathways): Design and Procedures of The Hispanic/Latino Cancer Survivorship Study.
1/2023	Neighborhood Disadvantage and Breast Cancer-Specific Survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael H Antoni Research Topics

Disease

27	Neoplasms (Cancer) 04/2024 - 02/2004
26	Breast Neoplasms (Breast Cancer) 03/2024 - 10/2006
8	Fatigue 01/2019 - 01/2003
5	Pain (Aches) 12/2022 - 05/2010
5	Prostatic Neoplasms (Prostate Cancer) 08/2015 - 02/2004
4	HIV Infections (HIV Infection) 10/2023 - 09/2003
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 03/2003
4	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2018 - 01/2013
3	Neoplasm Metastasis (Metastasis) 05/2022 - 02/2012
2	Anemia 12/2023 - 10/2023
2	Inflammation (Inflammations) 01/2021 - 01/2018
2	Syndrome (Syndromes) 10/2019 - 05/2010
2	Disease Progression 11/2013 - 09/2010
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2010 - 12/2004
2	Carcinoma (Carcinomatosis) 05/2010 - 01/2004
1	Neutropenia 12/2023
1	Thrombocytopenia (Thrombopenia) 12/2023
1	Leukopenia 10/2023
1	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2023
1	Carcinogenesis 05/2022
1	Overweight 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 10/2019
1	AIDS Dementia Complex 09/2013
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2011
1	Infections 09/2003
1	Herpes Genitalis (Genital Herpes) 03/2003

Drug/Important Bio-Agent (IBA)

10	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2023 - 01/2003
10	CytokinesIBA 01/2022 - 09/2003
5	beta-Aminoethyl Isothiourea (AET)IBA 02/2024 - 01/2021
5	Hormones (Hormone)IBA 02/2024 - 09/2003
3	LigandsIBA 05/2022 - 01/2019
3	Interleukin-2 (IL2)IBA 01/2018 - 07/2009
2	Biological FactorsIBA 04/2024 - 01/2023
2	NF-kappa B (NF-kB)IBA 03/2024 - 01/2021
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 05/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 05/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 08/2012
1	Transcription Factors (Transcription Factor)IBA 03/2024
1	Coe Comfort (FITT)IBA 12/2023
1	Filgrastim (Neupogen)FDA Link 10/2023
1	human ERBB2 proteinIBA 05/2023
1	Estrogen ReceptorsIBA 05/2023
1	SilverIBA 03/2023
1	Interleukin-1beta (Interleukin 1 beta)IBA 05/2022
1	Proteins (Proteins, Gene)FDA Link 05/2022
1	Receptor for Advanced Glycation End ProductsIBA 01/2022
1	Cyclin-Dependent Kinase 4IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2019
1	RNA (Ribonucleic Acid)IBA 10/2019
1	Cocaine (Cocaine HCl)IBA 10/2019
1	amsonic acid (DAS)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	AndrogensIBA 08/2015
1	Dopamine (Intropin)FDA LinkGeneric 11/2013
1	N-acetyltalosaminuronic acid (NAT)IBA 09/2013
1	Molecular Probes (Molecular Probe)IBA 03/2013
1	Interferon Type IIBA 02/2012
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2011
1	Interferon-gamma (Interferon, gamma)IBA 07/2009
1	Immunoglobulin G (IgG)IBA 03/2003

Therapy/Procedure

24	Therapeutics 03/2024 - 03/2003
9	Drug Therapy (Chemotherapy) 12/2023 - 11/2014
5	Aftercare (After-Treatment) 01/2022 - 05/2005
3	Radiotherapy 09/2010 - 01/2004
2	Adjuvant Chemotherapy 12/2023 - 10/2023
2	Prostatectomy (Retropubic Prostatectomy) 09/2010 - 01/2004
2	Highly Active Antiretroviral Therapy (HAART) 09/2003 - 03/2003
1	Tertiary Prevention 04/2024
1	Drug Tapering 12/2023
1	Neoadjuvant Therapy 10/2023
1	Segmental Mastectomy (Lumpectomy) 01/2018
1	Mastectomy (Mammectomy) 01/2018
1	Pain Management 12/2013
1	Activities of Daily Living (ADL) 01/2013
1	Treatment Delay 11/2010
1	Cognitive Training 10/2006
1	Ambulatory Care (Outpatient Care) 12/2004